Fulgent Genetics, Inc.: A Closer Look at the Securities Class Action Lawsuit The Legal Battle Unfolds On October 9, 2022, the law firm of Kessler Topaz Meltzer & Check, LLP announced the filing of a securities class action lawsuit against Fulgent Genetics, Inc. The lawsuit, filed in the United States District Court for the Central…

Revolutionizing Oncology: Radiomedix Secures $40 Million in Series A Financing for Groundbreaking Targeted Alpha Therapy and Diagnostic Radiopharmaceuticals HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) — RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related to Portland Investment Counsel Inc. (“Portland”) involving an equity investment of…

Capital Southwest Announces Preliminary Estimate of Second Quarter 2023 Operating Results Overview DALLAS, Oct. 07, 2022 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” the “Company” or “we”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to…

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems! Get ready for an experience like no other! Exciting news for all those in the pharmaceutical industry! Are you passionate about staying ahead of the curve in the world of pharmaceutical microbiology? Do you want to be at…

Annapolis based Community Redevelopment Highlights Plans to Enhance Stockholder Value and Updates Board Governance Annapolis, Oct. 03, 2022 GLOBE NEWSWIRE – Community Redevelopment, Inc. (CRDV), today announced corporate governance actions consistent with the Company’s efforts to drive long-term value creation for all stakeholders. In a Board of Director’s Meeting… Community Redevelopment, Inc. Announces Board of…

ATFX Welcomes Phil Muldoon as New Institutional Sales Director: A Veteran Leader in the Finance Industry ATFX announced that Phil Muldoon, an industry leader, had officially joined the company’s institutional business as Institutional Sales Director. As the brand continues to expand its global influence, ATFX has partnered with Phil, an experienced leader, to execute its…

Welcome to the Quirky World of Urica Therapeutics! Meet the Newest Addition to the Urica Therapeutics Family Urica Therapeutics, Inc. has recently announced the appointment of seasoned biotech executive, Jay D. Kranzler, M.D., Ph.D., as their latest addition to the team. This exciting news comes as a positive development for the company, which is dedicated…

Attention Stitch Fix Investors: Don’t Miss This Deadline! Rosen, Top-Ranked Investor Counsel, Urges You to Secure Legal Representation for Securities Class Action Against SFIX Are you a Stitch Fix investor? If so, you may want to pay attention to this important deadline. Rosen Law Firm, a global investor rights law firm, is reminding purchasers of…